DESIGN, FORMULATION AND CHARACTERIZATION OF VENLAFAXINE HYDROCHLORIDE EXTENDED RELEASE MULTIPARTICULATE SYSTEMS
Ajay Babu CH.*, Maddala Sumathi, M. Varalakshmi, K. Tirumala Devi and M. Prasada Rao
Abstract
The main objective of present investigation is to formulate and
evaluate the extended release pellets of venlafaxine hydrochloride a
weakly basic and antidepressant drug belongs to serotoninnorepinephrine
reuptake inhibitor class having high permeability and
high solubility. Rational use of the selection of dosage form is to
minimize variation in residence time, less susceptible to dose dumping,
to facilitate accurate delivery of small quantity of potent drug, reduced
potential side effects without lowering drug bio-availability. Extended
release pellets of venlafaxine hydrochloride were prepared employing
different concentrations of eudragit, ethylcellulose, hypromellose and
surelease in different combinations as a rate retarding polymer by using drug layering
technique. The quantity of polymers to achieve the desired extended drug release about 20
hours and the similarity with the reference product was determined. Totally 8 formulations
were prepared and are evaluated for hardness, friability, drug content, In-vitro drug release.
From the Results it was concluded that all the formulations were found to be within the
Pharmacopoeial limits and the In-vitro dissolution profiles of all formulations were fitted in
to different Kinetic models, the statistical parameters like intercept (a), slope (b) & regression
coefficient (r) were calculated.. Formulation F8 containing combination of 10% ethyl
Cellulose N-50, 13.9% polyethylene gylcol-6000 and 13.6% hypromellose, is the most
similar formulation when compared with that of marketed product. The optimized
formulation follows first order kinetics and Higuchi’s model, and hence, the mechanism of
drug release was found to be diffusion controlled.
Keywords: Venlafaxine hydrochloride, Extended Release, pellets, Ethylcellulose, Eudragit.
[Full Text Article]